Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Patent
1992-07-22
1996-04-09
Stone, Jacqueline M.
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
424 936, 4242321, 4241991, 435 691, 4353201, A61K 39275, A61K 39395, C12N 1586, C12P 2106
Patent
active
055059414
ABSTRACT:
The present invention provides a method for inducing an immunological response in a mammal or avian host to a pathogen by inoculating the mammal or avian host with a synthetic recombinant avipox virus modified by the presence, in a non-essential region of the avipox genome, of DNA from any source which codes for and expresses an antigen of the pathogen. The present invention further provides a synthetic recombinant avipox virus modified by the insertion therein of DNA from any source, and particularly from a non-avipox source, into a non-essential region of the avipox genome.
REFERENCES:
patent: 4603112 (1986-07-01), Paoletti et al.
patent: 4722848 (1988-10-01), Paoletti et al.
patent: 4769330 (1988-09-01), Paoletti et al.
patent: 5174993 (1992-12-01), Paoletti
Moss, "Poxviridae and Their Replication", in Fundamental Virology, 2nd Ed, B. N. Fields and D. M. Knipe, eds, Raven Press, NY, 1991, p. 954.
Ballay, A. et al. 1985, EMBO Journal vol. 4 pp. 3861-3865.
Boyle, D. B. et al. 1986, J. Gen. Virol. vol. 67 pp. 1591-1600.
Paoletti, E. et al. 1986, Biotechnology: Potentials and Limitations, Ed. S. Silver, Springer-Verlag, New York, pp. 155-164.
Binns, M. M. et al. 1986, Isr. J. Vet. Med. vol. 42 pp. 124-127.
Schacter, J. 1980, In: Manual of Clinical Microbiology 3rd Ed., E. H. Lennette et al, Am. Soc. for Microbiology, pp. 357-364.
Sarver, N. et al. 1981. Molec. Cell. Biol. vol. 1 pp. 486-496.
Mungal, S. et al. 1992, J. Virol. pp. 3220-3224.
Tratschin, J. D. et al. 1985. Molec. Cell. Biol. vol. 5 pp. 3251-3260.
Moss, B. 1985. "Replication of Poxviruses", in Virology, Ed. B. N. Fields et al, Raven Press, NY, pp 685-703.
Roizman, B. 1985, "Multiplication of Viruses: An Overview", in Virology, Ed. B. N. Fields et al, Raven Press, NY, pp. 69-75.
Somogyi, P. et al. 1993, Virology vol. 197 pp. 439-444.
Langrige, W. H. R. 1983, J. Invert. Pathol. vol 42 pp. 77-82.
Sambrook, J. et al. 1989, Molecular Cloning, Cold Spring Harbor Laboratory Press, Cold Spring Harbor NY, p. 8.47.
Andrewes, et. al., (1978), Viruses of Vertebrates. Cassell & Co. Ltd. p. 374.
Babinet, C. et al., 1985, Science 230 pp. 1160-1163.
Ballay, A. et al. 1985. The EMBO Journal 4, No. 13B. pp. 3861-3865.
Baxby, D., Progr. Med. Virol. 19, (1975), 215-246.
Beveridge, W. L. B. and L. Hart (1985) Animal Health in Australia, 7, p. 58.
Bossart, et. al, chem. Abstr. 89, (1978) 56,251n.
Boyle, D. B., et al., Virus Research, 10 (1988), p. 343.
Boyle, D. B., et. al., Virology, 156, p. 355, 1987.
Bruner, D. W., (1963), Diseases Transmitted from Animals to Man, (ed. Hull, T. G), charles C. Thomas, Publisher p. 394.
Buxton, A., (1977) Animal Microbiology, Blackwell Scientific Publications. p. 693.
Campione-Piccardo et. al., J. Virol. 31, 281-287 (1979).
Choi, W. S., et. al., J. Virol. 1991, 65, pp. 2875-2883.
Colbere-Garapin, Proc. Natl. Acad. Sci. USA 76, 3755-3759 (1979).
Comparative Diagnosis of Viral Diseases, vol. III, ch. 6, p. 277, Academic Press, New York, 1981.
Comprehensive Virology, Fraenkel-Conrad et. al., vol. 3, Ch. 5, pp. 405, 427, Plenum Press, New York.
Dalrymple, J. M., (1989), Vaccinia-vectored vaccines for exotic disease immunizaton programmes. In: Vacciniavectored Vaccines-Risks and Benefits (ed. F. A. Murphy) 2nd Forum in Virology. Institut Pasteur, Elsevier, 140, p. 479.
Downie, A. W., et. al., Ann. Rev. Microbiol. 10, 237-252 (1956).
Drillien, R., et. al. Virology, 160, p. 203 (1987).
Ensinger, et. al., "Marker Rescue . . . " J. Virol. 48(2); 1983, 419-428.
Esposito, J. J. and F. A. Murphy (1989) Infectious recombinant vectored virus vaccines, In: Vaccine Biotechnology 33, (ed. Bittle, J. L. and F. A. Murphy), Academic Press, p. 235.
Evans, D. H., et. al., J. Virol., Feb., 1988, 62, p. 367.
Fenner, et. al., Virology 5, 502-529 (1958).
Fenner, et. al., (1987), In: Veterinary Virology, Chapter 21, Academic Press, pp. 403-404.
Fenner, et. al., Virology, 8, 499-507, (1959).
Geigenmuller-Gnirke, Ute, et. al., Proc. Natl. Acad. Sci., USA, 88, pp. 3253-3257, (1991).
Gillespie, J. H., and J. F. Timoney (1981) Hagan and Bruner's Infectious Diseases of Domestic Animals. Cornell University Press. p. 531.
Graham, et. al., Virology 52, 456-467, (1973).
Graham, Tibtech 8, 85-87, (Apr. 1990).
Hagino-Yamagishi, et. al., J. Virol. 63, 5386-5392 (1989).
Hagino-Yamagishi, et. al., Chapter 14, New Aspects of Positive-Strand RNA Viruses (American Society for Microbiology, Wash. D.C.) ed. M. A. Brinton et. al.
Hamer, et. al., Nature 281, 35-40 (1979).
Hofstad, et. al., (1972) Diseases of Poultry, The Iowa University Press, p. 707.
Huang, et. al, J. Virol. 64, 5669-5673 (1990).
Joklik, Wolfgang K., Bacteriological Reviews, 30, 33-66, 1966.
Katz, et. al., C.A. 89 #39241s, (1978), of J. Antimicrob. Chemother. 1978 4(2): 159-162, Genetic Recombination Between Temperature Sensitive Mutant and IBT Resistant Mutant of Vaccinia Virus.
Kitson, et. al., J. Virol. 65, 3068-3075, (1991).
Langridge, W. H. R., 1984, Biological Abstr. vol. 77, p. 402, Abstr. 3598.
Levis, et. al., J. Virol. 64, 1726-1733 (1990).
Lyles, D. S., et. al., (1976), Cellular fatty acids during fowlpox virus infection of three different host systems, Virology, 70, p. 227.
Mackett, M., et. al, Proc. Natl. Acad. Sci. USA 79, 1982, 7415-7419.
Mackett, et. al, J. Gen. Virol. 45, (1979) 683-701.
Mackett, M. and G, K, Smith (1986), Vaccinia virus expression vectors, J. Gen. Virol. 67, p. 2078.
Mann, R. et. al, 1983, Cell, 33, pp. 153-159.
Matthews, R. E. F., (1982), Classification and Nomenclature of Viruses, Intervirology, 17, p. 43.
Melnick, Virology, Second Edition ed. B. N. Fields, (Raven Press, N.Y.), Chapter 21, 549-605, (1990).
Merck Veterinary Manual, (1986) ed. Fraser et. al., p., 1324.
Mocarski, et. al., Cell 22, 243, (1980).
Morse, L. S., et. al., J. Virol. 26, 389, (1978).
Moss, et. al., Chem. Abstr. vol. 95, (1981), p. 217, 559k.
Moss, et. al., J. Virol. 40, No. 2, (1981), pp. 387-389, & 393-395.
Muller, et. al., J. Gen. Virol. 38 (1977), 135-147.
Nakano, et. al., Proc. Natl. Acad. Sci. USA, 79, (1982), pp. 1593-1596.
Panicali, D., et. al., J. Virol. 37, 1000-1010, (1981).
Panicali, D., et. al., Proc. Natl. Acad. Sci. USA 80, 1983, 5364-5368.
Panicali, D., et. al., Proc. Natl. Acad. Sci. USA 79, 4927-4931 (1982).
Paoletti, E., et. al., Biotechnology: Potentials and Limitations (Dahlem Konferenzen 1986), pp. 155, 161-162.
Paoletti, E., et. al., Proc. Natl. Acad. Sci. USA 81, pp. 193-197, (1984).
Pattnaik, et. al., Proc. natl. Acad. Sci., USA 88, 1379-1383, 1991.
Pattnaik, et. al., J. Virol. 64, 2948-2957, (1990).
Piccini, et. al., BIoessays, 1986, 5, 249-251.
Prevec, et. al., J. Gen. Virol. 70, 429-434, (1989).
Post, et. al., Cell 25, (1981), 227-232.
Pouwels, P. H., et. al., Cloning Vectors (1985), p. VIII-A-a-i-9.
Rhodes, A. J., et. al., (1968) Textbook of Virology. The Williams and Wilkins Co.
Salter, D. W., et. al., 1987, Virology, 157, pp. 236-240.
Sam, et. al., Ann. Virol. 132 E. 135-150 (1981).
Sarver, et. al., Mol. Cell. Biol. 1, 486-496 (1981).
Schacter, J. 1980, In: Manual of clinical Microbiology 3rd ed. E. H. Lennette et. al. American Soiciety for Microbiology pp. 357-364, H.R. 1984, Biological Abstract vol. 77, p. 402, Abstre. 3598.
Schnitzlein, W. M., et. al., Virus Research, 10, (1988), p. 65.
Shimotohno, et. al., Cell 26, 66-77, (1981).
Smiley, Nature 285, (1980), 333-335.
Smith, et. al., Proc. Natl. Acad. Sci. 80, (1983), 7155-7159.
Smith, et. al., Nature 302, 490-495, 1983.
Sveda, et. al., Proc. Natl. Acad. Sci. 78, 5488-5492 (1981).
Tartaglia, J., et. al., Immunochemistry of Viruses II, ed. M. H. B. van Regenmorten, et. al, (Elsevier Science Publ.) 125-151 (1990).
Third Poxvirus-Iridovirus Workshop, Sep. 15-18, 1980, Workshop Program.
Villarreal et. al., Science 196, 183-185 (1977).
Virology, Dulbecco et. al., Ch. 56, pp. 1079 and 1082-1085, Harper & Row, Hagerstown.
Watanabe, S. et. al. 1983, Molecular and Cellular Biology 3, pp. 2241-2249.
Weir, et. al., Proc. Natl, Acad. Sci. USA 79, 1982, 1210-1214.
Wigler, et. al., Proc. Nat. Acad. Sci. USA, 76, 1373-1376 (1979).
Wigler, et. al., Cell 11, 223-232, (1977).
Wild, F., et. al., Vaccine 8, 441,
Crouch Deborah
Health Research , Inc.
Stone Jacqueline M.
LandOfFree
Recombinant avipox virus and method to induce an immune response does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant avipox virus and method to induce an immune response, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant avipox virus and method to induce an immune response will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-137091